Key result
The efficacy of paracetamol in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants could not be determined due to a truncated abstract.
Why the study?
Does paracetamol improve outcomes in preterm infants with patent ductus arteriosus who are ibuprofen-resistant or contraindicated?
Population
Preterm infants with patent ductus arteriosus who are ibuprofen-resistant or contraindicated
Authors
Loading...
Insufficient evidence to guide paracetamol for resistant PDA; leaves open its role pending complete prospective data.
Does paracetamol improve outcomes in preterm infants with patent ductus arteriosus who are ibuprofen-resistant or contraindicated?
Paracetamol is being explored as an alternative treatment for patent ductus arteriosus in preterm infants when standard cyclooxygenase inhibitors are contraindicated or ineffective.
Öncel et al. (2012) studied Patent ductus arteriosus (hsPDA). Paracetamol was evaluated. The efficacy of paracetamol in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants could not be determined due to a truncated abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: